AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic

  11 March 2021

The COVID-19 pandemic is predicted to impact the transmission of bacterial infections and the emergence of antibiotic resistance (AMR). The likely positive influence on antibiotic resistance that social distancing, increased awareness and the use of interventions to prevent the transmission of COVID-19 has had could also be counteracted by the reported excessive use of broad spectrum antibiotics to treat patients infected with SARS-CoV-2. Antimicrobial stewardship programmes and AMR focussed research activities must remain active during the COVID-19 and future pandemics, in order to safeguard against an uncontrolled rise in AMR.

Author(s): Jesús Rodríguez-Baño et al
Effective Surveillance   Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!